Nuvation Bio Inc. (NUVB) Tops Q3 EPS by 1c, Beats on Revenue
Tweet
Share
E-mailGet Alerts NUVB Hot Sheet
Join SI Premium – FREE
Nuvation Bio Inc. (NYSE: NUVB) reported Q3 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $13.12 million versus the consensus estimate of $6.8 million.
For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts Amalgamated Bank (AMAL) at Outperform
- Goldman Sachs Reiterates Buy Rating on HP Enterprise (HPE)
- Hyperscale Data chairman plans open-market stock purchases
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
